Pure Global
NCT06300944

The Effect of Esketamine on Postoperative Pain Relief in Patients Undergoing Laparoscopic Surgery

The Effect of Low-dose Ketamine on Postoperative Pain Relief and Sleep Quality in Patients Undergoing Laparoscopic Uterine Surgery
General Hospital of Ningxia Medical University·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Postoperative Pain
Drug/Device/Intervention
saline
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
General Hospital of Ningxia Medical University
Location
Yinchuan, China
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Oct 01, 2024
Enrollment
108 participants
Primary outcome

Moderate to severe pain,Incidence of adverse reactions including nausea, vomiting and dizziness,Sleep quality

Summary

The purpose of this study is to investigate whether continuous intraoperative infusion of
 esketamine combined with the addition of esketamine to postoperative PCIA can improve
 postoperative pain and sleep quality in patients undergoing laparoscopic uterine surgery
 under general anesthesia.

ICD-10 classifications
Acute painPostoperative intestinal obstructionPain, unspecifiedDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06300944
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06300944 through Pure Global AI's free database. This phase not specified trial is sponsored by General Hospital of Ningxia Medical University and is currently Recruiting. The study focuses on Postoperative Pain. Target enrollment is 108 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.